Viewing Study NCT05413551


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-25 @ 9:36 PM
Study NCT ID: NCT05413551
Status: COMPLETED
Last Update Posted: 2025-12-17
First Post: 2022-06-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
Sponsor: Stanford University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 65808
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View
None OTHER View
None UNKNOWN View